New Analyst Forecast: $NEE Given $67.0 Price Target

We just received data on a new analyst forecast for $NEE. Betty Jiang from Barclays set a price target of 67.0 for NEE.

To track analyst ratings and price targets for $NEE, check out Quiver Quantitative's $NEE forecast page.

$NEE Price Targets

Multiple analysts have issued price targets for $NEE recently. We have seen 8 analysts offer price targets for $NEE in the last 6 months, with a median target of $90.0.

Here are some recent targets:

• Betty Jiang from Barclays set a target price of $67.0 on 07/10/2025
• David Arcaro from Morgan Stanley set a target price of $94.0 on 06/18/2025
• William Appicelli from UBS set a target price of $84.0 on 05/23/2025
• Neil Kalton from Wells Fargo set a target price of $97.0 on 04/24/2025
• James Thalacker from BMO Capital set a target price of $77.0 on 04/14/2025
• Shahriar Pourreza from Guggenheim set a target price of $89.0 on 03/20/2025
• Jeremy Tonet from JP Morgan set a target price of $91.0 on 03/11/2025

$NEE Congressional Stock Trading

Members of Congress have traded $NEE stock 12 times in the past 6 months. Of those trades, 5 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $NEE stock by members of Congress over the last 6 months:

• REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 3 times. They made 3 purchases worth up to $45,000 on 06/06, 05/05, 01/21 and 0 sales.
• REPRESENTATIVE JEFFERSON SHREVE has traded it 2 times. They made 1 purchase worth up to $50,000 on 04/17 and 1 sale worth up to $100,000 on 05/12.
• REPRESENTATIVE RICK LARSEN sold up to $15,000 on 04/09.
• REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 04/08.
• REPRESENTATIVE JARED MOSKOWITZ sold up to $15,000 on 04/07.
• REPRESENTATIVE DWIGHT EVANS sold up to $15,000 on 04/03.
• REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 1 purchase worth up to $15,000 on 01/15 and 1 sale worth up to $15,000 on 04/01.
• REPRESENTATIVE GEORGE WHITESIDES sold up to $100,000 on 03/24.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$NEE Insider Trading Activity

$NEE insiders have traded $NEE stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $NEE stock by insiders over the last 6 months:

• CHARLES E SIEVING (EVP, Chief Legal) has made 0 purchases and 2 sales selling 41,684 shares for an estimated $3,007,880.
• JAMES MICHAEL MAY (VP, Controller and CAO) sold 2,383 shares for an estimated $162,258

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$NEE Hedge Fund Activity

We have seen 1,291 institutional investors add shares of $NEE stock to their portfolio, and 1,187 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• JPMORGAN CHASE & CO added 8,713,718 shares (+10.5%) to their portfolio in Q1 2025, for an estimated $617,715,469
• WELLINGTON MANAGEMENT GROUP LLP added 8,610,646 shares (+224.8%) to their portfolio in Q1 2025, for an estimated $610,408,694
• PRICE T ROWE ASSOCIATES INC /MD/ added 6,587,582 shares (+28.4%) to their portfolio in Q1 2025, for an estimated $466,993,687
• GQG PARTNERS LLC added 6,352,798 shares (+58.4%) to their portfolio in Q1 2025, for an estimated $450,349,850
• D. E. SHAW & CO., INC. removed 5,953,344 shares (-97.5%) from their portfolio in Q1 2025, for an estimated $422,032,556
• CAPITAL RESEARCH GLOBAL INVESTORS removed 4,993,991 shares (-59.0%) from their portfolio in Q1 2025, for an estimated $354,024,021
• DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 4,233,017 shares (-38.4%) from their portfolio in Q1 2025, for an estimated $300,078,575

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.